Related Experiment Videos
Immunological studies in cattle exposed to polybrominated biphenyls
Environmental Health Perspectives
|April 1, 1978
Summary
Polybrominated biphenyls (PBBs) exposure did not significantly impact the immune system in cattle. Studies found no adverse effects on hematological parameters, lymphocyte subpopulations, or immune responses in PBB-exposed animals.
Area of Science:
- Veterinary immunology
- Environmental toxicology
- Animal health
Background:
- Polybrominated biphenyls (PBBs) are persistent organic pollutants with potential immunotoxic effects.
- Assessing the impact of PBBs on cattle immunity is crucial for animal health and food safety.
Purpose of the Study:
- To investigate the intactness of the immune system in cattle exposed to varying levels of PBBs.
- To determine if PBB exposure affects hematological parameters, lymphocyte populations, or immune responses.
Main Methods:
- Utilized comprehensive immunoassays on 87 cattle (35 control, 52 PBB-exposed).
- Assessed complete blood counts, T and B lymphocyte subpopulations, immunoglobulin levels (IgG, IgM, IgA), and in vitro lymphocyte responses to mitogens.
- Evaluated antibody response to Keyhole limpet hemocyanin (KLH), cell-mediated response to PPD, and screened for autoantibodies and immunosuppressive factors.
Main Results:
- No statistically significant differences were observed between control and PBB-exposed cattle in hematological parameters, lymphocyte counts, immunoglobulin concentrations, or responses to KLH and PPD.
- Cattle with PBB tissue levels >3 ppm/g showed no immunological differences compared to controls.
- Serum from PBB-exposed cattle did not exhibit cytotoxic or immunosuppressive activity on lymphocytes from control cattle or humans.
Conclusions:
- PBB exposure, at the levels studied, does not appear to compromise the immune system in cattle.
- PBBs did not alter lymphocyte antigens, cell division processes, antibody formation, or cell-mediated immunity.
- No evidence suggests PBB exposure predisposes cattle to autoantibody production or leucotoxic serum factors.